Purpose :
Ocular manifestations of GVHD are known to occur in 60–90% of patients with chronic GVHD, and these manifestations primarilyaffect the cornea, conjunctiva, lacrimal glands, eyelid and meibomian glands. Dry eye disease (DED), or keratoconjunctivitissicca (KCS), is the most common manifestation of ocular GVHD. We evaluated the changes of an ocular surface and meibomian glandsafter HSCT associated with related with symptoms for the dry eye.

Methods :
This retrospective, noncomparative, observational study was approved by the Seoul St Mary’s Hospital Institutional Review Board.This study included the patients who had systemic or ocular inflammatory diseases or retinal diseases were excluded. The enrolled patients were checked up on visual acuity, intra ocular pressure (IOP), slit lamp examinationss to confirm the corneal surface and the tear function, and meibography before and after HSCT; one, two, and 3 months, respectively. Simultaneously, the degree of subjective symptoms about dry eye was also investigated.